Notably, the Ozempic group showed an HR of 1.72 (95% CI 1.671.76), and the Wegovy group presented a significantly higher HR of 2.14 (95% CI 2.052.24)
Patients carrying specific variants at these loci often show attenuated responses to semaglutide monotherapy compared to those with favorable genetic profiles
However, the prescribing information for Wegovy (another semaglutide product) does have a warning about avoiding use of the drug in people with a history of suicidal thoughts or behaviors
The decision to escalate is a clinical judgment call, ideally made jointly with your prescriber based on actual data (weight, side effects, appetite ratings) rather than a fixed calendar schedule
Numbness or tingling becomes constant rather than intermittent
Fishers Medical Weight Loss Centers, we acknowledge that GLP-1 medication is a potent tool in the battle against obesity, but it is not a magic solution on its own